Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000594544 | SCV000707417 | uncertain significance | not provided | 2017-03-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001455111 | SCV001658864 | likely benign | Sitosterolemia | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002341530 | SCV002642543 | likely benign | Cardiovascular phenotype | 2019-08-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003962711 | SCV004781738 | likely benign | ABCG5-related disorder | 2020-04-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |